The emergence and re-emergence of infectious diseases continue to pose significant global health challenges. Advances in genomic sequencing technologies have transformed public health surveillance by enabling rapid detection, characterization, and monitoring of pathogens. Genomic surveillance has become a critical component of infectious disease management, supporting outbreak investigation, transmission tracking, antimicrobial resistance monitoring, and public health decision-making.

Objective

This study evaluates the role of genomic surveillance in infectious disease management and examines its impact on outbreak detection, pathogen evolution monitoring, antimicrobial resistance surveillance, and healthcare preparedness.

Methods

A multicenter observational study was conducted using surveillance data from 30 public health laboratories and healthcare institutions. Genomic sequencing records, outbreak investigations, and epidemiological data from infectious disease surveillance programs were analyzed. Statistical analyses included descriptive statistics, trend analysis, and comparative outcome assessments.

Results

Genomic surveillance significantly improved outbreak detection speed, variant identification, antimicrobial resistance monitoring, and transmission mapping. Institutions implementing genomic surveillance demonstrated a 42% reduction in outbreak response time and a 36% improvement in pathogen source identification accuracy compared with traditional surveillance methods.

Conclusion

Genomic surveillance represents a transformative tool in infectious disease management. Integration of sequencing technologies into public health systems enhances disease detection, supports evidence-based interventions, and strengthens global preparedness against emerging infectious threats.